IL1B and inflammatory bowel disease: These results can be explained by the study conducted by Brenna et al. [19], where the expression of guanylin was found to negatively correlate with the expression of pro-inflammatory cytokines (TNF-α, IL-1β) in inflamed biopsies collected from patients with IBD.